Works matching IS 00278874 AND DT 2023 AND VI 115 AND IP 9

Results: 14
    1

    Reviewers.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 9, p. 1112, doi. 10.1093/jnci/djad157
    Publication type:
    Article
    2
    3
    4

    Circulating proteome for pulmonary nodule malignancy.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 9, p. 1060, doi. 10.1093/jnci/djad122
    By:
    • Moez, Elham Khodayari;
    • Warkentin, Matthew T;
    • Brhane, Yonathan;
    • Lam, Stephen;
    • Field, John K;
    • Liu, Geoffrey;
    • Zulueta, Javier J;
    • Valencia, Karmele;
    • Mesa-Guzman, Miguel;
    • Nialet, Andrea Pasquier;
    • Atkar-Khattra, Sukhinder;
    • Davies, Michael P A;
    • Grant, Benjamin;
    • Murison, Kiera;
    • Montuenga, Luis M;
    • Amos, Christopher I;
    • Robbins, Hilary A;
    • Johansson, Mattias;
    • Hung, Rayjean J
    Publication type:
    Article
    5

    Adjuvant endocrine therapy uptake, toxicity, quality of life, and prediction of early discontinuation.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 9, p. 1099, doi. 10.1093/jnci/djad109
    By:
    • Balazard, Félix;
    • Bertaut, Aurélie;
    • Bordet, Élise;
    • Mulard, Stéphane;
    • Blanc, Julie;
    • Briot, Nathalie;
    • Paux, Gautier;
    • Merimeche, Asma Dhaini;
    • Rigal, Olivier;
    • Coutant, Charles;
    • Fournier, Marion;
    • Jouannaud, Christelle;
    • Soulie, Patrick;
    • Lerebours, Florence;
    • Cottu, Paul-Henri;
    • Tredan, Olivier;
    • Vanlemmens, Laurence;
    • Levy, Christelle;
    • Mouret-Reynier, Marie-Ange;
    • Campone, Mario
    Publication type:
    Article
    6
    7
    8
    9
    10

    Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 9, p. 1001, doi. 10.1093/jnci/djad096
    By:
    • Singh, Simron;
    • Hope, Thomas A;
    • Bergsland, Emily B;
    • Bodei, Lisa;
    • Bushnell, David L;
    • Chan, Jennifer A;
    • Chasen, Beth R;
    • Chauhan, Aman;
    • Das, Satya;
    • Dasari, Arvind;
    • Rivero, Jaydira Del;
    • El-Haddad, Ghassan;
    • Goodman, Karyn A;
    • Halperin, Daniel M;
    • Lewis, Mark A;
    • Lindwasser, O Wolf;
    • Myrehaug, Sten;
    • Raj, Nitya P;
    • Reidy-Lagunes, Diane L;
    • Soares, Heloisa P
    Publication type:
    Article
    11
    12
    13

    Copy number aberrations in circulating tumor DNA enables prognosis prediction and molecular characterization of breast cancer.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 9, p. 1036, doi. 10.1093/jnci/djad080
    By:
    • Kim, Min Hwan;
    • Kim, Gun Min;
    • Ahn, Jin Mo;
    • Ryu, Won-Ji;
    • Kim, Seul-Gi;
    • Kim, Jee Hung;
    • Kim, Tae Yeong;
    • Han, Hyun Ju;
    • Kim, Jee Ye;
    • Park, Hyung Seok;
    • Park, Seho;
    • Park, Byeong Woo;
    • Kim, Seung Il;
    • Jeong, Joon;
    • Lee, Jieun;
    • Paik, Soonmyung;
    • Kim, Sangwoo;
    • Jung, Kyung Hae;
    • Cho, Eun Hae;
    • Sohn, Joohyuk
    Publication type:
    Article
    14

    Lung cancer risk discrimination of prediagnostic proteomics measurements compared with existing prediction tools.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 9, p. 1050, doi. 10.1093/jnci/djad071
    By:
    • Feng, Xiaoshuang;
    • Wu, Wendy Yi-Ying;
    • Onwuka, Justina Ucheojor;
    • Haider, Zahra;
    • Alcala, Karine;
    • Smith-Byrne, Karl;
    • Zahed, Hana;
    • Guida, Florence;
    • Wang, Renwei;
    • Bassett, Julie K;
    • Stevens, Victoria;
    • Wang, Ying;
    • Weinstein, Stephanie;
    • Freedman, Neal D;
    • Chen, Chu;
    • Tinker, Lesley;
    • Nøst, Therese Haugdahl;
    • Koh, Woon-Puay;
    • Muller, David;
    • Colorado-Yohar, Sandra M
    Publication type:
    Article